• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

PD-L1 内源性抑制剂的研究:cAMP 作为一种潜在的候选药物。

Study on endogenous inhibitors against PD-L1: cAMP as a potential candidate.

机构信息

School of Medicine and Pharmacy, Ocean University of China, Qingdao, Shandong 266003, PR China.

School of Medicine and Pharmacy, Ocean University of China, Qingdao, Shandong 266003, PR China; Laboratory of Marine Drugs and Biological Products, Pilot National Laboratory for Marine Science and Technology, Qingdao, Shandong 266235, PR China.

出版信息

Int J Biol Macromol. 2023 Mar 1;230:123266. doi: 10.1016/j.ijbiomac.2023.123266. Epub 2023 Jan 14.

DOI:10.1016/j.ijbiomac.2023.123266
PMID:36646351
Abstract

The discovery of new anti-cancer drugs targeting the PD-1/PD-L1 pathway has been a research hotspot in recent years. In this study, biological affinity ultrafiltration (BAU), UPLC-HRMS, molecular dynamic (MD) simulations and molecular docking methods were applied to search for endogenous active compounds that can inhibit the binding of PD-L1 to PD-1. We screened dozens of potential cancer related endogenous compounds. Surprisingly, cyclic adenosine monophosphate (cAMP) was found to have a direct inhibitory effect on the PD-1/PD-L1 binding with an in vitro IC value of about 36.4 ± 9.3 μM determined by homogeneous time-resolved fluorescence (HTRF) assay. cAMP could recover the proliferation of Jurkat T cells co-cultured with DU-145 cells and may suppress PD-L1 expression of DU-145 cells. cAMP was demonstrated to bind and induce PD-L1 dimerization by FRET assay, and also predicted by MD simulations and molecular docking. The finding of cAMP as a potential inhibitor directly targeting the PD-1/PD-L1 interaction could advance our understanding of the activity of endogenous compounds regulating PD-L1.

摘要

近年来,针对 PD-1/PD-L1 通路的新型抗癌药物的发现一直是研究热点。在这项研究中,应用生物亲和力超滤(BAU)、UPLC-HRMS、分子动力学(MD)模拟和分子对接方法,搜索能够抑制 PD-L1 与 PD-1 结合的内源性活性化合物。我们筛选了数十种潜在的与癌症相关的内源性化合物。令人惊讶的是,环磷酸腺苷(cAMP)被发现对 PD-1/PD-L1 的结合具有直接抑制作用,通过均相时间分辨荧光(HTRF)测定,其体外 IC 值约为 36.4±9.3 μM。cAMP 可以恢复与 DU-145 细胞共培养的 Jurkat T 细胞的增殖,并可能抑制 DU-145 细胞中 PD-L1 的表达。通过荧光共振能量转移(FRET)测定、MD 模拟和分子对接预测,证明 cAMP 可以结合并诱导 PD-L1 二聚化。cAMP 作为一种直接靶向 PD-1/PD-L1 相互作用的潜在抑制剂的发现,可以加深我们对内源性化合物调节 PD-L1 活性的认识。

相似文献

1
Study on endogenous inhibitors against PD-L1: cAMP as a potential candidate.PD-L1 内源性抑制剂的研究:cAMP 作为一种潜在的候选药物。
Int J Biol Macromol. 2023 Mar 1;230:123266. doi: 10.1016/j.ijbiomac.2023.123266. Epub 2023 Jan 14.
2
Design, synthesis, pharmacological evaluation, and computational study of benzo[d] isothiazol-based small molecule inhibitors targeting PD-1/PD-l1 interaction.基于苯并[d]异噻唑的小分子 PD-1/PD-L1 相互作用抑制剂的设计、合成、药理评价及计算研究。
Eur J Med Chem. 2024 Sep 5;275:116622. doi: 10.1016/j.ejmech.2024.116622. Epub 2024 Jun 29.
3
Discovery of benzo[d]isothiazole derivatives as novel scaffold inhibitors targeting the programmed cell death-1/programmed cell death-ligand 1 (PD-1/PD-L1) interaction through "ring fusion" strategy.通过“环融合”策略发现苯并[d]异噻唑衍生物作为靶向程序性细胞死亡蛋白1/程序性细胞死亡配体1(PD-1/PD-L1)相互作用的新型支架抑制剂。
Bioorg Chem. 2022 Jun;123:105769. doi: 10.1016/j.bioorg.2022.105769. Epub 2022 Apr 4.
4
Design, synthesis, and biological evaluation of 1-methyl-1H-pyrazolo[4,3-b]pyridine derivatives as novel small-molecule inhibitors targeting the PD-1/PD-L1 interaction.设计、合成及生物评价 1-甲基-1H-吡唑并[4,3-b]吡啶衍生物作为新型小分子 PD-1/PD-L1 相互作用抑制剂
Bioorg Chem. 2021 Sep;114:105034. doi: 10.1016/j.bioorg.2021.105034. Epub 2021 May 30.
5
Is the Triggering of PD-L1 Dimerization a Potential Mechanism for Food-Derived Small Molecules in Cancer Immunotherapy? A Study by Molecular Dynamics.食物来源的小分子在癌症免疫治疗中诱导 PD-L1 二聚化的潜在机制?分子动力学研究。
Int J Mol Sci. 2023 Jan 11;24(2):1413. doi: 10.3390/ijms24021413.
6
Discovery of quinazoline derivatives as novel small-molecule inhibitors targeting the programmed cell death-1/programmed cell death-ligand 1 (PD-1/PD-L1) interaction.发现喹唑啉衍生物作为新型小分子抑制剂,靶向细胞程序性死亡-1/细胞程序性死亡配体 1(PD-1/PD-L1)相互作用。
Eur J Med Chem. 2022 Feb 5;229:113998. doi: 10.1016/j.ejmech.2021.113998. Epub 2021 Nov 18.
7
Synthesis and pharmacological evaluation of novel resorcinol biphenyl ether analogs as small molecule inhibitors of PD-1/PD-L1 with benign toxicity profiles for cancer treatment.新型间苯二酚联苯醚类似物的合成与药理评价,作为 PD-1/PD-L1 的小分子抑制剂,具有良性毒性特征,可用于癌症治疗。
Biochem Pharmacol. 2021 Jun;188:114522. doi: 10.1016/j.bcp.2021.114522. Epub 2021 Mar 17.
8
Design, synthesis, evaluation, and SAR of 4-phenylindoline derivatives, a novel class of small-molecule inhibitors of the programmed cell death-1/ programmed cell death-ligand 1 (PD-1/PD-L1) interaction.设计、合成、评价及 4-苯基吲哚衍生物的 SAR 研究:一类新型的程序性死亡受体 1/程序性死亡配体 1(PD-1/PD-L1)相互作用小分子抑制剂。
Eur J Med Chem. 2021 Feb 5;211:113001. doi: 10.1016/j.ejmech.2020.113001. Epub 2020 Nov 10.
9
Kaempferol and Its Glycoside, Kaempferol 7-O-Rhamnoside, Inhibit PD-1/PD-L1 Interaction In Vitro.山奈酚及其糖苷、山奈酚 7-O-鼠李糖苷在体外抑制 PD-1/PD-L1 相互作用。
Int J Mol Sci. 2020 May 3;21(9):3239. doi: 10.3390/ijms21093239.
10
Molecular Mechanism of Small-Molecule Inhibitors in Blocking the PD-1/PD-L1 Pathway through PD-L1 Dimerization.小分子抑制剂通过 PD-L1 二聚化阻断 PD-1/PD-L1 通路的分子机制。
Int J Mol Sci. 2021 Apr 30;22(9):4766. doi: 10.3390/ijms22094766.

引用本文的文献

1
Discovery of PD-L1 Peptide Inhibitors from Ascidian Enzymatic Hydrolysates by Affinity Ultrafiltration Coupled to NanoLC-MS/MS.通过亲和超滤结合纳升液相色谱-串联质谱法从海鞘酶解产物中发现程序性死亡受体配体1(PD-L1)肽抑制剂
Mar Drugs. 2025 Mar 21;23(4):137. doi: 10.3390/md23040137.